Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and langerhans cell migration

PLoS Pathogens

Volumn 8, Issue 7, 2012, Pages 23-

  Sperling, Tanya ^a   Ołdak, Monika ^b,c   Walch Rückheim, Barbara ^b   Wickenhauser, Claudia ^a,d   Doorbar, John ^e   Pfister, Herbert ^a   Malejczyk, Magdalena ^f   Majewski, Sławomir ^f   Keates, Andrew C ^g   Smola, Sigrun ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Division of Virology   (Germany)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN E6; PROTEIN E7; VIRUS PROTEIN; CCL20 PROTEIN, HUMAN; CEBPB PROTEIN, HUMAN; DNA BINDING PROTEIN; ONCOPROTEIN;

ARTICLE; BINDING SITE; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; DNA BINDING; EPIDERMIS; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE DELETION; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 8; IMMUNOSURVEILLANCE; IN VIVO STUDY; KERATINOCYTE; LANGERHANS CELL; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRATUM CORNEUM; VIRUS PARTICLE; WART VIRUS; BETAPAPILLOMAVIRUS; CELL CULTURE; CELL MOTION; ENHANCER REGION; GENETICS; IMMUNOLOGY; METABOLISM; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PHYSIOLOGY; SKIN TUMOR; TUMOR CELL LINE; VIROLOGY;

HUMAN PAPILLOMAVIRUS TYPE 8; PAPILLOMAVIRIDAE;

BETAPAPILLOMAVIRUS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL20; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; EPIDERMIS; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; KERATINOCYTES; LANGERHANS CELLS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS;

EID: 84864622798     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002833     Document Type: Article

References (76)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007) Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90: 1-636.
3. Pfister H, (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31: 52-56.
4. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, et al. (2005) Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65: 1394-1400.
5. Viarisio D, Mueller-Decker K, Kloz U, Aengeneyndt B, Kopp-Schneider A, et al. (2011) E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog 7: e1002125.
6. Dong W, Kloz U, Accardi R, Caldeira S, Tong WM, et al. (2005) Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 79: 14899-14908.
7. Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, et al. (2003) The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 77: 2195-2206.
8. Paradisi A, Waterboer T, Sampogna F, Tabolli S, Simoni S, et al. (2011) Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br J Dermatol 165: 782-791.
9. Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, et al. (2010) Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 70: 9777-9786.
10. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, et al. (2006) Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98: 389-395.
11. Orth G, (2008) Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol 321: 59-83.
12. Dell'Oste V, Azzimonti B, De Andrea M, Mondini M, Zavattaro E, et al. (2009) High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 129: 1026-1034.
13. Haller K, Stubenrauch F, Pfister H, (1995) Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 214: 245-255.
14. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579-581.
15. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, et al. (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205: 35-42.
16. Jakob T, Ring J, Udey MC, (2001) Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 108: 688-696.
17. Haftek M, Jablonska S, Szymanczyk J, Jarzabek-Chorzelska M, (1987) Langerhans cells in epidermodysplasia verruciformis. Dermatologica 174: 173-179.
18. van Voorst Vader PC, de Jong MC, Blanken R, Kallenberg CG, Vermey A, et al. (1987) Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics. Arch Dermatol Res 279: 366-373.
19. Cooper KD, Androphy EJ, Lowy D, Katz SI, (1990) Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 94: 769-776.
20. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, et al. (1999) Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J Exp Med 190: 1755-1768.
21. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, et al. (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24: 191-201.
22. Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, et al. (2001) Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2: 1151-1158.
23. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, et al. (2000) Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192: 705-718.
24. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, et al. (2002) Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 11: 135-142.
25. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suarez-Farinas M, et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159: 1092-1102.
26. Tohyama M, Shirakara Y, Yamasaki K, Sayama K, Hashimoto K, (2001) Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein 3alpha/CCL20, a potent chemokine for Langerhans cells. J Dermatol Sci 27: 130-139.
27. Nakayama T, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, et al. (2001) Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13: 95-103.
28. Schutyser E, Struyf S, Menten P, Lenaerts JP, Conings R, et al. (2000) Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J Immunol 165: 4470-4477.
29. Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF, (2001) Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 280: G710-719.
30. Harant H, Eldershaw SA, Lindley IJ, (2001) Human macrophage inflammatory protein-3alpha/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-alpha via a non-standard NF-kappaB site. FEBS Lett 509: 439-445.
31. Kwon JH, Keates S, Simeonidis S, Grall F, Libermann TA, et al. (2003) ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells. J Biol Chem 278: 875-884.
32. Doorbar J, Coneron I, Gallimore PH, (1989) Sequence divergence yet conserved physical characteristics among the E4 proteins of cutaneous human papillomaviruses. Virology 172: 51-62.
33. Egawa K, (1994) New types of human papillomaviruses and intracytoplasmic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol 130: 158-166.
34. Borgogna C, Zavattaro E, De Andrea M, Griffin HM, Azzimonti B, et al. (2012) Characterization of Beta Papillomavirus E4 Expression in Tumours from Epidermodysplasia Verruciformis Patients and in Experimental Models. Virology 423: 195-204.
35. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
36. Agarwal C, Efimova T, Welter JF, Crish JF, Eckert RL, (1999) CCAAT/enhancer-binding proteins. A role in regulation of human involucrin promoter response to phorbol ester. J Biol Chem 274: 6190-6194.
37. Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF, et al. (1999) C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol Cell Biol 19: 7181-7190.
38. Maytin EV, Habener JF, (1998) Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110: 238-246.
39. Smith C, Zhu K, Merritt A, Picton R, Youngs D, et al. (2004) Regulation of desmocollin gene expression in the epidermis: CCAAT/enhancer-binding proteins modulate early and late events in keratinocyte differentiation. Biochem J 380: 757-765.
40. Muller S, Kammerbauer C, Simons U, Shibagaki N, Li LJ, et al. (1995) Transcriptional regulation of intercellular adhesion molecule-1: PMA-induction is mediated by NF kappa B. J Invest Dermatol 104: 970-975.
41. Bomsztyk K, Rooney JW, Iwasaki T, Rachie NA, Dower SK, et al. (1991) Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. Cell Regul 2: 329-335.
42. Goethe R, Basler T, Phi-van L, (2007) Regulation of C/EBPbeta mRNA expression and C/EBPbeta promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11). Inflamm Res 56: 274-281.
43. Solito E, de Coupade C, Parente L, Flower RJ, Russo-Marie F, (1998) Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ 9: 327-336.
44. Yang Y, Pares-Matos EI, Tesmer VM, Dai C, Ashworth S, et al. (2002) Organization of the promoter region of the human NF-IL6 gene. Biochim Biophys Acta 1577: 102-108.
45. Agresti A, Scaffidi P, Riva A, Caiolfa VR, Bianchi ME, (2005) GR and HMGB1 interact only within chromatin and influence each other's residence time. Mol Cell 18: 109-121.
46. Descombes P, Schibler U, (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579.
47. Phelps WC, Munger K, Yee CL, Barnes JA, Howley PM, (1992) Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol 66: 2418-2427.
48. Sugita S, Kohno T, Yamamoto K, Imaizumi Y, Nakajima H, et al. (2002) Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation. J Immunol 168: 5621-5628.
49. Imaizumi Y, Sugita S, Yamamoto K, Imanishi D, Kohno T, et al. (2002) Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway. Int Immunol 14: 147-155.
50. Fujiie S, Hieshima K, Izawa D, Nakayama T, Fujisawa R, et al. (2001) Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB]. Int Immunol 13: 1255-1263.
51. Jackson S, Harwood C, Thomas M, Banks L, Storey A, (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14: 3065-3073.
52. Muller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, et al. (1999) Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways. Proc Natl Acad Sci U S A 96: 7276-7281.
53. Guess JC, McCance DJ, (2005) Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 79: 14852-14862.
54. Caberg JH, Hubert P, Herman L, Herfs M, Roncarati P, et al. (2009) Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother 58: 39-47.
55. Dreier K, Scheiden R, Lener B, Ehehalt D, Pircher H, et al. (2011) Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ. Virology 409: 54-68.
56. Massimi P, Pim D, Banks L, (1997) Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. J Gen Virol 78 (Pt 10): 2607-2613.
57. Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, et al. (1999) Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci U S A 96: 1291-1296.
58. Muller-Schiffmann A, Beckmann J, Steger G, (2006) The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J Virol 80: 8718-8728.
59. Howie HL, Koop JI, Weese J, Robinson K, Wipf G, et al. (2011) Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog 7: e1002211.
60. Schmitt A, Harry JB, Rapp B, Wettstein FO, Iftner T, (1994) Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol 68: 7051-7059.
61. Enzenauer C, Mengus G, Lavigne A, Davidson I, Pfister H, et al. (1998) Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. Intervirology 41: 80-90.
62. Habig M, Smola H, Dole VS, Derynck R, Pfister H, et al. (2006) E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity. Arch Virol 151: 1961-1972.
63. de Koning M, Quint W, Struijk L, Kleter B, Wanningen P, et al. (2006) Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 44: 1792-1800.
64. Peh WL, Doorbar J, (2005) Detection of papillomavirus proteins and DNA in paraffin-embedded tissue sections. Methods Mol Med 119: 49-59.
65. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, et al. (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 77: 10186-10201.
66. Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ, Smola-Hess S, (2003) The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol 77: 5253-5265.
67. Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H, et al. (2005) Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 86: 1291-1296.
68. Smola-Hess S, de Silva US, Hadaschik D, Pfister HJ, (2001) Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner. J Gen Virol 82: 2335-2339.
69. Oldak M, Tolzmann L, Wnorowski A, Podgorska MJ, Silling S, et al. (2011) Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7. J Virol 85: 178-188.
70. Oldak M, Smola H, Aumailley M, Rivero F, Pfister H, et al. (2004) The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J Virol 78: 10738-10746.
71. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, et al. (1993) Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res 53: 5328-5333.
72. Oldak M, Maksym RB, Sperling T, Yaniv M, Smola H, et al. (2010) Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. J Virol 84: 1376-1386.
73. Schroer N, Pahne J, Walch B, Wickenhauser C, Smola S, (2011) Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res 71: 87-97.
74. Dole VS, Smola H, Dooley S, Said HM, Oldak M, et al. (2009) The adenoviral E1A oncoprotein activates the Smad7 promoter: requirement of a functional E-box. Int J Oncol 35: 1493-1498.
75. Falk MM, Lauf U, (2001) High resolution, fluorescence deconvolution microscopy and tagging with the autofluorescent tracers CFP, GFP, and YFP to study the structural composition of gap junctions in living cells. Microsc Res Tech 52: 251-262.
76. Dignam JD, Lebovitz RM, Roeder RG, (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.